American Bio Medica
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.67-6.19-10.10-8.35-5.35-2.01-3.34-5.80-3.46-0.18-0.29-5.35
Price/Sales ratio
0.320.410.530.510.590.530.621.110.720.280.440.53
Price/Book Value ratio
2.163.123.502.814.68-14.18-2.88-3.68-1.69-0.11-0.27-0.27
Price/Cash Flow ratio
321.6830.9514.6211.9616.13-9.4139.25-9.57-2.38-0.34-0.76-0.76
Price/Free Cash Flow ratio
-115.80131.9016.0913.6624.96-8.5539.25-9.49-2.38-0.34-0.76-0.76
Price/Earnings Growth ratio
0.120.150.262.71-0.11-0.020.08-0.800.06-0.000.00-0.11
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
40.16%42.03%45.19%44.39%40.63%33.26%32.39%29.85%24.70%-21.13%-16.42%33.26%
Operating Profit Margin
-12.71%-2.97%-3.57%-4.58%-6.32%-19.67%-16.22%-14.97%-53.15%-136.03%-132.50%-19.67%
Pretax Profit Margin
-8.83%-6.69%-5.23%-6.07%-11.09%-26.49%-18.76%-19.14%-20.78%-154.21%-150.79%-26.49%
Net Profit Margin
-8.85%-6.72%-5.27%-6.15%-11.09%-26.54%-18.63%-19.19%-20.87%-154.43%-151.06%-26.54%
Effective Tax Rate
-0.25%-0.40%-0.60%-1.17%-42.93%-0.19%0.72%-0.25%-0.43%-0.14%-0.18%-42.93%
Return on Assets
-15.86%-12.01%-8.77%-10.23%-18.85%-41.53%-32.77%-41.32%-24.58%-111.11%-172.49%-41.53%
Return On Equity
-58.89%-50.51%-34.65%-33.65%-87.47%704.10%86.20%63.37%49.04%60.28%118.69%-87.47%
Return on Capital Employed
-70.29%-15.78%-10.92%-14.45%-21.99%-117.23%-151.66%653.68%125.29%53.23%82.29%-21.99%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.21N/A
Quick Ratio
0.450.470.500.500.320.320.240.310.310.100.030.32
Cash ratio
0.190.130.090.090.020.060.000.040.040.000.000.06
Days of Sales Outstanding
35.9040.7838.8236.1825.8442.6036.9435.82118.97113.5320.6542.60
Days of Inventory outstanding
142.03148.83184.08185.13184.31143.93119.6467.2596.82125.0782.00143.93
Operating Cycle
177.94189.61222.91221.31210.16186.54156.59103.07215.80238.6187.09186.54
Days of Payables Outstanding
42.5935.4339.3235.5746.7950.7196.3072.39149.05250.81164.4346.79
Cash Conversion Cycle
135.35154.18183.58185.73163.36135.8360.2830.6766.74-12.19-123.55135.83
Debt Ratios
Debt Ratio
0.440.530.470.430.450.620.710.930.831.752.840.45
Debt Equity Ratio
1.652.241.881.432.09-10.51-1.89-1.43-1.67-0.95-1.54-10.51
Long-term Debt to Capitalization
N/A0.250.490.420.551.223.48-8.23N/AN/A-0.001.22
Total Debt to Capitalization
0.620.690.650.580.671.102.113.292.48-20.45-22.621.10
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-6.53N/A
Cash Flow to Debt Ratio
0.000.040.120.160.13-0.140.03-0.26-0.42-0.34-0.37-0.14
Company Equity Multiplier
3.714.203.953.284.64-16.95-2.63-1.53-1.99-0.54-0.54-0.54
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.000.010.030.040.03-0.050.01-0.11-0.30-0.84-0.58-0.05
Free Cash Flow / Operating Cash Flow Ratio
-2.770.230.900.870.641.111.001110.64
Cash Flow Coverage Ratio
0.000.040.120.160.13-0.140.03-0.26-0.42-0.34-0.37-0.14
Short Term Coverage Ratio
0.000.050.260.330.33-0.290.14-0.70-0.42-0.34-0.38-0.29
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A